Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis

Journal of Magnetic Resonance Imaging

Volumn 42, Issue 5, 2015, Pages 1421-1430

  Chaudhury, Baishali ^a   Zhou, Mu ^a   Goldgof, Dmitry B ^a   Hall, Lawrence O ^a   Gatenby, Robert A ^b   Gillies, Robert J ^b   Patel, Bhavika K ^b   Weinfurtner, Robert J ^b   Drukteinis, Jennifer S ^b  

^a University of South Florida   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

axillary lymph node metastases; breast cancer; estrogen receptor; habitats; magnetic resonance imaging; textural kinetics

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER PROGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TUMOR MICROENVIRONMENT; AREA UNDER THE CURVE; BREAST; BREAST TUMOR; IMAGE ENHANCEMENT; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AREA UNDER CURVE; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84945446032     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24921     Document Type: Article

References (54)

1. Davnall F, Yip CS, Ljungqvist G, et al., Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012; 3: 573-589.
2. Kuukasjärvi T, Karhu R, Tanner M, et al., Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997; 57: 1597-1604.
3. Zhou M, Hall L, Goldgof D, et al., Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results, Transl Oncol 2014; 7: 5-13.
4. Gerlinger M, Rowan AJ, Horswell S, et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-892.
5. Swanton C,. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012; 72: 4875-4882.
6. Ng CK, Pemberton HN, Reis-Filho JS,. Breast cancer intratumor genetic heterogeneity: causes and implications. Expert Rev Anticancer Ther 2012; 12: 1021-1032.
7. Soussan M, Orlhac F, Boubaya M, et al., Relationship between tumor heterogeneity measured on fdg-pet/ct and pathological prognostic factors in invasive breast cancer. PloS one 2014; 9: e94017.
8. Shah SP, Morin RD, Khattra J, et al., Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009; 461: 809-813.
9. Leth-Larsen R, Terp MG, Christensen AG, et al., Functional heterogeneity within the cd44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol Med 2012; 18: 1109-1121.
10. Glaser S, Niemann U, Preim B, Spiliopoulou M,. Can we distinguish between benign and malignant breast tumors in DCE-MRI by studying a tumor?s most suspect region only? In: IEEE 26th International Symposium on Computer-Based Medical Systems (CBMS); 2013. p 77-82.
11. Mahrooghy M, Ashraf AB, Daye D, et al., Heterogeneity wavelet kinetics from DCE-MRI for classifying gene expression based breast cancer recurrence risk. In: Medical Image Computing and Computer-Assisted Intervention-MICCAI 2013; Berlin: Springer. p 295-302.
12. Yang X, Knopp MV,. Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol. 2011: 732-848.
13. Chen W, Giger ML, Li H, Bick U, Newstead GM. Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn Reson Med 2007; 58: 562-571.
14. Chaudhury B, Zhou M, Goldgof D.B, et al., Using features from tumor subregions of breast DCE-MRI for estrogen receptor status prediction. In: 2014 IEEE International Conference on Systems, Man and Cybernetics (SMC) 2014;2624-2629.
15. Otsu N,. A threshold selection method from gray-level histograms. Automatica 1975; 11: 285-296: 23-27.
16. Sonka M, Hlavac V, Boyle R,. Image processing, analysis, and machine vision, Cengage Learn 2014 [Epub ahead of print].
17. Karahaliou A, Vassiou K, Arikidis N, Skiadopoulos S, Kanavou T, Costaridou L,. Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis. Br J Radiol 2014; 83: 296-309.
18. Uppuluri A,. (November 20, 2008), GLCM texture features. Available at http://www.mathworks.com/matlabcentral/fileexchange/22187-glcm-texture-features.
19. Haralick R, Shanmugam K, Dinstein I,. Textural features for image classification. IEEE Transactions on Systems, Man and Cybernetics 1973; 3: 610-621.
20. Wei X,. (November 12, 2007), Gray level run length matrix toolbox v1. 0, Software, Beijing Aeronautical Technology Research Center. Available at http://www.mathworks.com/matlabcentral/fileexchange/17482-gray-level-run-length-matrix -toolbox.
21. Ahonen T, Matas J, He C, Pietikainen M., Rotation invariant image description with local binary pattern histogram Fourier features. In: Image analysis. Berlin: Springer; 2009. p 61-70.
22. Hall MA,. Correlation-based feature selection for machine learning. PhD thesis, University of Waikato 1999.
23. Kohavi R, John GH,. Wrappers for feature subset selection. Artif Intel 1997; 97: 273-324.
24. John GH, Langley P,. Estimating continuous distributions in Bayesian classifiers. In: Proceedings of the Eleventh Conference on Uncertainty in Artificial Intelligence. Burlington, MA: Morgan Kaufmann; 1995. p 338-345.
25. Quinlan JR,. C4. 5: programs for machine learning, vol. 1. Burlington, MA: Morgan Kaufmann; 1993.
26. Chang CC, Lin CJ,. Libsvm: a library for support vector machines. ACM Transactions on Intelligent Systems and Technology 2011; 2: 27.
27. El-Manzalawy Y, Honavar V., Wlsvm,: Integrating libsvm into weka environment. 2005. Available at http://www.cs.iastate.edu/yasser/wlsvm.
28. Powers DM,. Evaluation: from precision, recall and f-measure to roc, informedness, markedness and correlation. J Machine Learn Technol 2011; 2: 37-63.
29. Linfoot E,. An informational measure of correlation. Inform Control 1957; 1: 85-89.
30. Li C, Meng S, Yang X, Wang J, Hu J,. The value of t2∗ in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer-a preliminary in vivo study. PloS One 2014; 9: e84038.
31. Bhooshan N, Giger ML, Jansen SA, Li H, Lan L, Newstead GM,. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. Radiology 2010; 254: 680-690.
32. Tuncbilek N, Tokatli F, Altaner S, et al., Omurlu K, Temizoz O,. Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients. Eur J Radiol 2012; 81: 863-867.
33. Jensen LR, Garzon B, Heldahl MG, et al., Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging 2011; 34: 1099-1109.
34. Rahbar H, Partridge SC, Javid SH, Lehman CD,. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer. Curr Probl Diagnost Radiol 2012; 41: 149-158.
35. Jinguji M, Kajiya Y, Kamimura K, e al. Rim enhancement of breast cancers on contrast enhanced MR imaging: relationship with prognostic factors. Breast Cancer 2006; 13: 64-73.
36. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S,. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors 1. Radiology 2000; 217: 841-848.
37. Teifke A, Behr O, Schmidt M, et al., Dynamic MR imaging of breast lesions: Correlation with microvessel distribution pattern and histologic characteristics of prognosis 1. Radiology 2006; 239: 351-360.
38. Chen JH, Baek H, Mehta R, Carpenter P, Nalcioglu O, Su M,. MR imaging features of triple negative breast cancer. Breast J 2013; 19: 643-649.
39. Agner S, Rosen M, Englander S, et al., Distinguishing molecular subtypes of breast cancer based on computer-aided diagnosis of DCE-MRI. In: International Society for Magnetic Resonance in Medicine Annual Meeting 2010, Vol. 2490.
40. Golden DI, Lipson JA, Telli ML, Ford JM, Rubin DL,. Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer. J Am Med Inform Assoc 2013; 20: 1059-1066.
41. Chen JH, Baek HM, Nalcioglu O, Su MY,. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging 2008; 27: 825-833.
42. Milenkovic J, Hertl K, Kosir A, Zibert J, Tasic JF,. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions. Artif Intell Med 2013; 58: 101-114.
43. Chaudhury B, Hall LO, Goldgof DB, Gatenby RA, Gillies R, Drukteinis JS,. New method for predicting estrogen receptor status utilizing breast MRI texture kinetic analysis. In: SPIE Medical Imaging, International Society for Optics and Photonics 2014. p 90351V-90351V.
44. Chaudhury B, Zhou M, Hall LO, et al., Using features from tumor subregions of breast DCE-MRI for estrogen receptor status prediction. In: Press Systems, Man and Cybernetics, 2014.
45. Pickles MD Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1-10.
46. Twellman T, Lichte O, Nattkemper TW. An adaptive tissue characterization network for model-free visualization of dynamic contrast-enhanced magnetic resonance image data. IEEE Transactions on Medical Imaging; 2004; 24: 1256-1266.
47. Mohajer M, Cluster analysis of the signal curves in perfusion DCE-MRI datasets. PhD thesis, lmu, 2012.
48. Eyal E, Badikhi D, Furman-Haran E, Kelcz F, Kirshenbaum KJ, Degani H,. Principal component analysis of breast DCE-MRI adjusted with a model-based method. J Magn Reson Imaging 2009; 30: 989-998.
49. Chen L, Choyke PL, Chan TH, Chi CY, Wang G, Wang Y,. Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors. IEEE Transactions on Medical Imaging; 2011; 30: 2044-2058.
50. Eyal E, Degani H,. Model-based and model-free parametric analysis of breast dynamic-contrast-enhanced MRI. NMR Biomed 2009; 22: 40-53.
51. Agner SC, Xu J, Fatakdawala H, et al., Segmentation and classification of triple negative breast cancers using DCE-MRI. In: Biomedical Imaging: From Nano to Macro, 2009. ISBI'09. IEEE International Symposium; 2009. p 1227-1230.
52. Cheng L, Li X,. Breast magnetic resonance imaging: kinetic curve assessment. Gland Surg 2013; 2: 50-53.
53. Rastogi P, Anderson SJ, Bear HD, et al., Preoperative chemotherapy: updates of National Surgical Adjuvant. J Clin Oncol 2008; 26: 778-785.
54. Raina V, Kunjahari M, Shukla NK, et al., Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: data from a tertiary cancer center in northern India. Indian J Cancer 2011; 48: 80.